California Lab Finds New Clues In Popular Heartburn Drug's Possible Cancer Link
The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the Food and Drug Administration.
